Liver and GB remainder of part I and part II Flashcards

1
Q

pathogenesis of alcoholic steatosis

A
  • increased lipogenesis
  • increase release of FA from fat cells
    increased storage of FA in the liver
  • increased lipolysis
  • decreased/lack of lipophagy
  • decreased adipokines
  • decreased release of VLDL from the liver
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pathogenesis of alcoholic steatohepatitis

A
  • cytokines by kupffer cells
  • ROS
  • toxic alcohol metabolites
  • fibrosis by stellate cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

etiology of cirrhosis

A
  • HBV
  • HCV
  • Alcoholic liver disease
  • Hemochromatosis
  • Nonalcoholic fatty liver disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

compensated cirrhosis

A

w or w/o gastroesophageal varices

No sign of hepatic damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

decomp cirrhosis

A

Jaundice
Hepatic encephalopathy
Ascites
Variceal hemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

portal hypertension

A

structural changes: fibrosis
dynamic changes: increased vasoconstrictors
decreased vasodilators

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ascites

A
  • Main clinical consequences of portal hypertension
  • portal hypertension -> Splanchnic Arterial Vasodilation -> Decrease in Effective Arterial Volume -> Decrease in Renal Blood Flow -> renin-angiotensin activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Clinical consequences of iron overload

A
  • increased non-transferrin-bound iron (NTBI)

- excess oxygen radicals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Hereditary Hemochromatosis

A
  • HFE gene mutation -> reduced hepcidin
  • Lipid peroxidation
  • Interaction of ROS and iron with DNA
  • Stimulation of collagen formation
  • Clinical consequence: Fibrosis and cirrhosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

HAV

A
  • no chronic infection
  • oral-fecal route
  • vaccination
  • lifelong immunity
  • Hepatocellular damage and destruction by HAV-specific CD8+ T lymphocytes and NK cells

Interferon-gamma

symptomes: Sudden onset of nausea, vomiting, anorexia, fever, malaise and abdominal pain
Within a few days to a week, dark urine, pale stools followed by jaundice and pruritus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

HBV

A
  • cccDNA -> chronic infection
  • blood, birth, bonking
  • Immune-mediated liver injury
    Cytotoxic T cell-mediated lysis
    Direct cytotoxic liver injury
    Role of viral variants
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

phases of HBV infection

A

Immune-tolerance phase
- HBeAg-positive
- high levels of HBV replication with normal ALT levels
- limited liver inflammation
Immune-clearance/reactive phase
- ALT levels are typically elevated or fluctuating,
- higher risk of liver fibrosis
Immune-control phase
- very low or undetectable HBV DNA levels
- normal ALT and minimal fibrosis progression
- anti-HBe positive
Immune-escape phase
- in some people
- rising HBV DNA levels despite HBeAg negativity
- caused by virions that do not express HBeAg because of genetic mutations
- anti-HBe positive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

HCV

A
  • mutation - > viral persistence -> chronic HCV hepatitis
    pathogenesis:
  • Chronic hepatitis C
  • Liver cirrhosis
  • Hepatocellular carcinoma
  • uses many cancer hallmarks
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

NAFLD types

A
  • NAFL: nonalcoholic fatty liver: hepatic steatosis is present without evidence of inflammation
  • NASH: nonalcoholic steatohepatitis may progress to cirrhosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

pathogenesis of NASH

A
  • Kupffer cells:
    pro-inflammatory mediators and pro-fibrotic factors
  • Stellate cells:
    fibrogenesis
  • Hepatocytes
    FC accumulation in the mitochondria -> ROS and lipid peroxidation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Clinical Features of NASH/NAFLD

A

Triad: insulin resistance, T2DM, obesity

17
Q

Insulin Resistance and NAFLD

A
  • hyperinsulinemia
  • hyperlipidemia
  • hyperglycemia
18
Q

HCC’s risk factors

A
  • cirrhosis
  • HBV
  • HCV
  • HH
  • alcohol
  • chronic liver disease/injury
  • aflatoxin
19
Q

HCC pathogenesis

A

repeated hepatocyte damage -> Stepwise accumulation

20
Q

Pathogenesis of Cholelithiasis

A

supersaturation of bile with cholesterol

hypomotility of the gallbladder

defective conversion of cholesterol to bile acids

hypersecretion of mucus in the gallbladder

21
Q

Cholelithiasis Clinical Features

A

biliary colic that may be excruciating

Cholecystitis, in association with stones, also causes pain

Pain is localized to right upper quadrant or epigastrium that may radiate to the right shoulder or the back

22
Q

Cholecystitis Pathogenesis

A

Acute calculous cholecystitis

  • chemical irritation and inflammation of a gallbladder obstructed by stones
  • prostaglandins released

Acute acalculous cholecystitis
- ischemia and trauma

Chronic Cholecystitis
- fibrosis and thickening of the gallbladder

23
Q

Cholestatic Liver Disease

A

hepatocellular: an impairment of bile formation
obstructive: abnormal bile flow occurs after it is formed

24
Q

Pathogenesis of Pruritus in Cholestatic Disease

A

Endogenous opioids

Lysophosphatidic acid and autotoxin

25
Q

Pathogenesis of Gallbladder Carcinoma

A
  • APBJ: reflux of pancreatic secretions into the biliary tree (liver, gallbl. and biliary ducts) -> KRAS mutation (is involved in cell growth/proliferation)
  • chronic gallstones -> inflam -> p53 mutation